Table 1.
Baseline Demographic Characteristics and Clinical Data for HD Patients
| Variable | All HD Patients (N = 33) |
|---|---|
| Primary renal diagnosis (%) | |
| Diabetic nephropathy | 24.2 [8] |
| Polycystic kidney disease | 15.2 [5] |
| Renovascular disease | 12.1 [4] |
| Glomerulonephritis | 24.2 [8] |
| Unknown cause | 12.1 [4] |
| Other known | 12.1 [4] |
| Length of time on HD (mo) | 5.5 ± 2.7 |
| Mean UF volume (l) | 1.7 ± 1.0 |
| Dialysis access (%) | |
| Fistula | 81.8 [27] |
| Graft | 3 [1] |
| Tunneled line | 15.2 [5] |
| Diabetes [%] | 24.2 [8] |
| Hypertension [%] | 60.6 [20] |
| Myocardial infarction [%] | 12.1 [4] |
| Ischemic heart disease [%] | 18.2 [6] |
| Stroke [%] | 15.2 [5] |
| Peripheral vascular disease [%] | 9.1 [3] |
| Systolic blood pressure (mm Hg) | 138 (131–155) |
| Diastolic blood pressure (mm Hg) | 78 (67–83) |
| Hemoglobin (mg/dl) | 111 (103–118) |
| Urea reduction ratio (%) | 73 (68–78) |
| Albumin (g/l) | 35 (32–36) |
| C-reactive protein (mmol/l) | 8 (3–14) |
| Phosphate (mmol/l) | 1.73 (1.33–2.18) |
| Corrected calcium (mmol/l) | 2.35 (2.24–2.39) |
| Parathyroid hormone (mmol/l) | 48.1 (24.5–85.9) |
| Galectin-3 (ng/ml) | 17.5 (13.4–22.0) |
| hs-Troponin Ta (pg/ml) | 33.7 (23.5–46.9) |
| NT-BNPa (pg/ml) | 1934 (1111–5111.5) |
| ECG QTcb (m/s) | 435 (412.8–453) |
ECG, electrocardiogram; HD, hemodialysis; hs-Troponin T, highly sensitive Troponin T; NT-proBNP, N-terminal β-natriuretic peptide 1; UF, ultrafiltration.
All data presented as percentage [number of participants], median (interquartile range), or mean ± SD, as appropriate.
a
hs-Troponin T and NT-BNP values were available for 31 HD participants.
b
QTc was available for 28 HD participants.